Abstract
Background Youth in South Africa are disproportionately affected by STIs, HIV, and unintended pregnancies. Despite this, their uptake of HIV and contraceptive services remains a challenge. South Africa urgently needs tailored, scalable interventions to address both HIV infection and early pregnancy prevention for young people. These interventions generally take years to design, implement, and evaluate, leaving a gap. To that end, we have developed a framework to translate the expected impact of facility-level attributes in increasing HIV/contraceptive service uptake for youth from a discrete choice experiment (DCE) into a cost effectiveness analysis (CEA).
Methods We used a DCE (n=805) conducted in Gauteng, South Africa, which found that staff attitude, confidentiality, Wi-Fi, subsidized food, afternoon hours and youth-only services were preferred attributes of health services. Based on this we simulated uptake of services adapted for these preferences. We divided preferences into modifiable attributes that could readily be adapted (e.g. Wi-Fi), and non-modifiable (more nuanced attributes that are more challenging to cost and evaluate): staff attitude and estimated the incremental change in uptake of services using adapted services. Costs for modifiable preferences were estimated using data from two clinics in South Africa (2019 US$). We determined the incremental cost effectiveness ratio (ICER) of 15 intervention combinations, and report the results of interventions on the cost-effectiveness frontier.
Results Greatest projected impact on uptake was from friendly and confidential services, both of which were considered non-modifiable (18.5% 95%CI:13.0-24.0%; 8.4% 95%CI:3.0-14.0% respectively). Modifiable factors on their own resulted in only small increases in expected uptake. (Food: 2.3% 95%CI:4.0%-9.00%; Wi-Fi: 3.0% 95%CI: -4.0%-10.0%; Youth only services: 0.3% 95%CI: -6.0%-7.0%; Afternoon services: 0.8% 95%CI: -6.0%-7.0%). The order of interventions on the cost-effectiveness frontier are Wi-Fi and youth-only services (ICER US$7.01-US$9.78), Wi-Fi, youth-only services and food (ICER US$9.32 - US$10.45), followed by Wi-Fi, youth-only services and extended afternoon hours (ICER US$14.46 – US$43.63)
Conclusion Combining DCE results and costing analyses within a modelling framework provides an innovative way to inform decisions on effective resource utilisation. Modifiable preferences, such as Wi-Fi provision, youth only services and subsidized food, have potential to cost-effectively increase the proportion of youth accessing HIV and contraceptive services.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was made possible by the generous support of the American People and the President's Emergency Plan for AIDS Relief (PEPFAR) through US Agency for International Development (USAID) under the terms of Cooperative Agreements AID-674-A-12-00029 and 72067419CA00004 to Health Economics and Epidemiology Research Office. LL was supported by the National Institute of Mental Health of the National Institutes of Health under grant number K01MH119923. The contents are the responsibility of the authors and do not necessarily reflect the views of the NIH, PEPFAR, USAID or the United States Government. The funders had no role in the study design, collection, analysis and interpretation of the data, in manuscript preparation or the decision to publish.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The original study protocol whose results informed this analysis was reviewed and approved by the Human Research Ethics Committee (Medical) (#170213) of the University of the Witwatersrand (HREC) and the Boston University Medical Campus Institutional Review Board (H-35987) of the Boston University School of Public Health. All participants provided written informed consent to participate in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses of authors: CG: cgovathson{at}heroza.org
LCL: lclong{at}bu.edu
AM: amoolla{at}heroza.org
SP: spascoe{at}heroza.org
BEN: brooken{at}bu.edu
CAR: c.a.russell{at}amsterdamumc.nl
Data Availability
All data produced in the present study are available upon reasonable request to the authors
